Proton-pumping complex I of the mitochondrial respiratory chain is among the largest and most complicated membrane protein complexes. The enzyme contributes substantially to oxidative energy conversion in eukaryotic cells. Its malfunctions are implicated in many hereditary and degenerative disorders. We report the x-ray structure of mitochondrial complex I at a resolution of 3.6 to 3.9 angstroms, describing in detail the central subunits that execute the bioenergetic function. A continuous axis of basic and acidic residues running centrally through the membrane arm connects the ubiquinone reduction site in the hydrophilic arm to four putative proton-pumping units. The binding position for a substrate analogous inhibitor and blockage of the predicted ubiquinone binding site provide a model for the "deactive" form of the enzyme. The proposed transition into the active form is based on a concerted structural rearrangement at the ubiquinone reduction site, providing support for a two-state stabilization-change mechanism of proton pumping.
Proton-pumping complex I of the mitochondrial respiratory chain is among the largest and most complicated membrane protein complexes. The enzyme contributes substantially to oxidative energy conversion in eukaryotic cells. Its malfunctions are implicated in many hereditary and degenerative disorders. We report the x-ray structure of mitochondrial complex I at a resolution of 3.6 to 3.9 angstroms, describing in detail the central subunits that execute the bioenergetic function. A continuous axis of basic and acidic residues running centrally through the membrane arm connects the ubiquinone reduction site in the hydrophilic arm to four putative proton-pumping units. The binding position for a substrate analogous inhibitor and blockage of the predicted ubiquinone binding site provide a model for the "deactive" form of the enzyme. The proposed transition into the active form is based on a concerted structural rearrangement at the ubiquinone reduction site, providing support for a two-state stabilization-change mechanism of proton pumping.
W ith a molecular mass of~1 MD, protonpumping NADH:ubiquinone oxidoreductase (complex I) is the largest membrane protein complex of the mitochondrial respiratory chain (1, 2) . Complex I couples electron transfer from NADH (reduced nicotinamide adenine dinucleotide) to ubiquinone to the translocation of four protons from the mitochondrial matrix to the intermembrane space (IMS), thereby providing much of the proton-motive force for adenosine triphosphate synthesis. Dysfunction of the enzyme is the most frequent cause of mitochondrial disorders (3) and has been implicated in numerous neurodegenerative conditions (4) . Complex I is also a major source of deleterious reactive oxygen species (5) . Mitochondrial complex I consists of 14 central subunits and a large number of accessory subunits. Specific inhibitors have been essential for unraveling structure-function relationships within complex I and are a focus of biomedical research, as some of them can induce Parkinson's disease (6) . The central subunits of complex I harboring the bioenergetic core functions are conserved from bacteria to humans. Complex I from bacteria and from mitochondria of Yarrowia lipolytica, a yeast genetic model for the study of eukaryotic complex I (7), were previously analyzed by x-ray crystallography (8) (9) (10) ). Yet the catalytic mechanism has remained enigmatic. Here, we present the x-ray structure of all central subunits and the largest accessory subunit of mitochondrial complex I from Y. lipolytica, providing insight into the molecular basis of redox-driven proton pumping.
Overall structure
Complex I was purified and crystallized as described (8) . Optimized cryoprotection and data collection improved x-ray diffraction in the best direction to 3.6 Å. Phases were obtained using single isomorphous replacement with anomalous scattering from highly redundant data of heavy-atom derivatives, FeS clusters, and selenomethionine. Phases were combined, averaged, and extended to the resolution of the native data set collected at 5 K. Model building with the 3.8 Å experimental electron density map was aided by the large content of a helices, close to 100 selenomethionine positions, and homology models based on the bacterial complexes (10, 11) . Secondary structure constraints were applied for refinement. Anisotropy correction counteracted the lower order of the crystals in the membrane plane, and the structure was refined at 3.9 Å × 3.9 Å × 3.6 Å (table S1 and fig. S1 ). The structure contains the majority of residues for central subunits and the largest accessory subunit (table S2) . Side chains are well resolved in tightly packed subunits with high helix content, and between 50 and 89% of the residues in these subunits could be assigned. The end of the peripheral hydrophilic domain is less ordered ( fig. S1 and table S1 ).
Mitochondrial complex I has a slightly opened L-shape with an angle of~120°between the two arms (Fig. 1) . The matrix arm protrudes into the organelle interior and is oriented perpendicular to the membrane plane and the membrane arm. The 14 central subunits forming the core of the complex are surrounded by the accessory subunits comprising 44% of the total mass. Complex I is 250 Å long and 190 Å high, with a width of 70 Å for the membrane arm and 120 Å for the matrix arm. The complex is organized in four functional modules (1, 8) . The distal half of the matrix arm, comprising the central 75-kDa, 51-kDa, and 24-kDa subunits, forms the N module that oxidizes NADH (nomenclature as for bovine complex I is used throughout the text). The proximal half of the peripheral arm, which comprises the central 49-kDa, 30-kDa, PSST, and TYKY subunits, is the Q module that reduces ubiquinone and docks onto the membrane arm. A chain of eight canonical FeS clusters (2) runs over a distance of~100 Å through the matrix arm (Fig. 1C) . The edge-to-edge distances for seven of these clusters are <14 Å, allowing fast electron tunneling (12) . This arrangement establishes an electron transfer path from the [4Fe-4S] cluster of the 51-kDa subunit (cluster N3) to the [4Fe-4S] cluster of PSST (cluster N2). Cluster N2 reduces ubiquinone and resides~30 Å above the membrane plane (8) . The slightly bent membrane arm features 82 transmembrane helices (TMHs), with 64 of them contributed by central subunits (Fig. 2A) . The proximal pump module (P P ) comprises central subunits ND1, ND2, ND3, ND4L, and ND6, whereas the distal pump module (P D ) contains central subunits ND4 and ND5 ( Fig. 2A) .
Membrane arm and proton-pumping modules
The largest membrane-embedded subunits, ND5, ND4, and ND2 ( Fig. 2A) , share a structurally highly similar core of 14 TMHs ( fig. S2 ) with two repeats of five TMHs (A, TMH4-8; B, TMH9-13) in inverted topology ( fig. S2 ). Each repeat features a discontinuous helix (TMH7a/b, TMH12a/b). Such helices are hallmarks of ion-translocating membrane proteins (13) (14) (15) . Indeed, ND5, ND4, and ND2 are homologous to the Mrp Na + /H + antiporter family, which suggests a role in proton pumping (8, 11, 16) . ND5 has a C-terminal extension with a lateral helix, >60 Å long, lining ND5, ND4, and ND2 on the concave side of the arm close to the matrix side ( Fig. 2A) , thus bridging the P P and P D modules. The C terminus of ND5 is anchored to ND2 via a V-shaped arrangement of TMH16 and TMH17. The lateral helix was previously identified in the low-resolution analysis of mitochondrial complex I from Y. lipolytica (8) and is also present in the bacterial (9, 11) and bovine complexes (17) , in which its C terminus is anchored by one TMH only. Whether this prominent structural element is involved in energy transduction for proton pumping, as proposed previously (8, 9) , remains controversial (2) .
Adjacent to ND2 are three small central subunits, ND4L, ND6, and ND3, which form two layers of straight helices crossing the membrane domain ( Fig. 2A and fig. S3A ). Notably, TMH3 . On the intermembranespace side, a long loop links THM4 ND6 to a short surface helix connecting to TMH5 ND6 , which is surrounded by helices of ND2, ND4L, and ND3. In the bacterial complex (9, 11), TMH4 ND6 sits closer to the core helices of ND6 at a position occupied in the mitochondrial complex by a single helix of an accessory subunit, tentatively identified as NUJM (17) . TMH1
ND3 is anchored remotely in a surface cleft of ND1. ND1 at the proximal end of the membrane arm comprises eight TMHs and noticeable loop regions, including short surface helices ( Fig. 2A and fig. S3B ). The fold of TMH2-6 is similar to one repeat of the antiporterlike subunits. This agrees with homology predictions (18) and was noted in the bacterial complex (10) . Notably, TMH5 is discontinuous in mitochondrial complex I.
The interior of the membrane arm is rich in polar and protonable residues (i.e., residues that may take up or release protons) constituting a remarkable hydrophilic central axis across all subunits (Fig. 2B ). Toward the matrix and IMS, each of the antiporter-like subunits has typical arrays of titratable and polar residues constituting possible proton uptake and release pathways ( Fig. 2B and fig. S4 ). For ND5 (Fig. 2B) ). A similar architecture is repeated in ND4 and ND2 ( fig. S4 ). Whereas the central network and the proposed proton exit routes are consistent with suggestions for the bacterial complex, the proposed routes for proton entry differ as they were assigned between TMH5 and TMH7 in bacteria (10, 19) .
In summary, all three antiporter-like subunits carry the structural signature of a proton-pumping unit with two structurally distinct discontinuous helices. Consistently, TMH7a/b contributes a central Lys residue that is next to a Glu of TMH5, and TMH12a/b is part of a central polar network connecting the proton exit route along TMH12b with the likely proton entry point at loops TMH7b-8 and TMH9-10 (Fig. 2B) . The dipoles of the discontinuous helices add to the polarity of the central axis, because the C termini of TMH7a and TMH12a point to the center of the membrane arm, thereby introducing evenly spaced negative partial charges along the arm. In contrast, the positive polarity of the N termini of TMH7b and TMH12b is directed away from the central axis toward the periphery of the membrane arm (Fig. 2, B and C) .
In line with a pump stoichiometry of 4H
, a fourth potential proton translocation pathway could be anticipated in the small NDs or ND1. From the neighboring residues Glu 30 and Glu 66 of ND4L and Glu 131 of ND2 continuing the central axis, a row of polar residues toward the IMS at the interface of ND2 and ND4L could serve as a proton exit (Fig. 2B and fig. S4 ). Directly above, a series of polar residues constitutes a potential fourth proton entry at the interface initially also proposed to be present in bacterial complex I (19 for proton uptake, replacing the one proposed earlier (19) . However, the structure of mitochondrial complex I suggests that the central axis of protonable residues is more likely to play a critical role in energy transmission.
Peripheral arm
The peripheral arm comprises the N module extending into the matrix and the Q module docking it onto the membrane arm. The central subunits of the Q module (the 49-kDa, PSST, TYKY, and 30-kDa subunits) are related to Ni-Fe hydrogenases (1, 21) . The 49-kDa subunit comprises two three-stranded antiparallel b sheets and several a helices. The longest helices form a prominent four-helix bundle inclined toward the membrane surface (Figs. 1 and 3) .
PSST protrudes toward the membrane surface (Figs. 1 and 3B ). TYKY provides contact to the N module. Its ferredoxin-type fold holds two [4Fe-4S] clusters (Fig. 3) . Its N-terminal helix a 1 docks onto ND1 and contacts the four-helix bundle of the 49-kDa subunit. The latter is also the docking site for the 30-kDa subunit, with a central five-stranded b sheet laterally surrounded by four a helices. In the N module, the 75-kDa subunit resides on the same side as PSST and coordinates one [2Fe-2S] and two [4Fe-4S] clusters (Figs. 1 and 3B) . The 51-kDa subunit located above the 49-kDa subunit holds one [4Fe-4S] cluster and contains the binding sites for FMN and NADH in a Rossman-fold domain. The 24-kDa subunit coordinates the [2Fe-2S] cluster detached from the electron transfer chain leading to cluster N2.
As noted previously (8) , the Q module is rotated outward about 3°relative to the N module as compared to bacterial complex I (10).
The largest accessory subunit, NUEM-an ortholog of the mammalian 39-kDa subunit-flanks the Q module and docks onto PSST ( fig. S5 ). It belongs to the family of short-chain dehydrogenases (SDRs). A characteristic Rossman fold typically found in all SDRs (22) is present in the N-terminal domain, with a central seven-stranded b sheet surrounded by five a helices (Fig. 3 and  fig. S5 ). NADH phosphate (NADPH) binding to Y. lipolytica complex I was shown experimentally (23) . The helices of the C-terminal domain characteristic for the subfamily of extended SDRs are in contact with the membrane arm, consistent with the reported cross-linking to ND3 (24) . Assembly defects of Y. lipolytica complex I in deletion mutants (23) suggest a structural role, but the function of NUEM remains elusive. Some additional accessory subunits were provisionally localized in the Y. lipolytica complex I structure ( fig. S6 ) on the basis of a model of supernumerary subunits of bovine complex I recently obtained by cryo-electron microscopy (17) .
Interface between peripheral and membrane arm and ubiquinone access
Structural elements of the ND1, ND3, 49-kDa, PSST, and TYKY subunits form the interface between the membrane and the peripheral arm (Fig. 3) (Fig. 4) . This loop is rich in acidic residues, protrudes into a cleft between PSST and 49-kDa subunit, and is in contact with 49-kDa loop b1-b2 (Pro 89 to Leu 98 ) of the N-terminal b sheet, where loop TMH1-2 ND3 also approaches. Because cluster N2 resides well above the membrane plane, an access path allowing the head group of the hydrophobic substrate ubiquinone to reach its electron donor is needed (25) . This path is provided by a quinone exchange cavity crossing the interface region. Its opening lies between TMH1 ND1 , TMH6
ND1
, and amphipathic helix a 1-2 ND1 positioned at the periphery of the matrix bilayer leaflet. The cavity extends~3 0 Å toward the tip of loop b1-b2 49-kDa (Fig. 4) . The small triangular-shaped entry pore is~7 Å wide and has a hydrophobic surface. The side chain of Ala 54 of a 1-2 ND1 points into the pore opening. In humans, substitution of the corresponding Ala 52 of ND1 with the larger Thr is among the most prevalent mutations leading to Leber's hereditary optic neuropathy and interferes with ubiquinone reduction (26) . Furthermore, substitution of Trp 77 in PSST (lining the inner side of the narrow entry passage) by Glu abolishes ubiquinone reductase activity (27) . The surface and immediate vicinity of the cavity exhibit a bipartite distribution of charged residues. Toward the surface of the complex, basic residues are present at the C-terminal end of TMH1 (Fig. 4 ).
Ubiquinone and inhibitor binding sites
To define the substrate and inhibitor binding sites within the Q module, we cocrystallized complex I with brominated derivatives of 2-decyl-4-quinazolinylamine (DQA; Fig. 5 ). DQA is a potent class I/A type inhibitor competitive to piericidin A (28) and shown to qualify as a true ubiquinone analog (29) . Brominating the quinazoline scaffold (QA-1) increased the halfmaximal inhibitory concentration (IC 50 ) from 17 nM for DQA to 320 nM, and replacing the side chain with a brominated phenylethylamine moiety (QA-2) hardly affected binding (IC 50 = 23 nM) ( fig. S7 ). Anomalous Fourier electron density maps (Fig. 5) positioned the bromine atoms close to each other in the vicinity of His 95 of the 49-kDa subunit at the deepest point of the quinone exchange cavity (Fig. 5B) . For both derivatives, the geometrical constraints imposed by anomalous signals and structure are consistent with an identical toxophore position; a quinazoline ring was modeled into the structure to visualize its likely position. The planar aromatic ring system stacks between the tip of loop
49-kDa and Met 91 of PSST (Fig. 5B) , placing the ring bromine at the quinazoline ring and the bromine in the tail moiety 14 Å and 16 Å away, respectively, from cluster N2. Supporting the notion that the position of the substrate analogs also reflects a binding site for ubiquinone, mu (27) are located nearby (Fig. 5) .
Some distinct structural features in mitochondrial complex I can explain a known functional difference to the bacterial enzyme: The quinone exchange cavity does not provide access to several other residues of the 49-kDa subunit (Asp 143 (29, 30) . Indeed, binding of ubiquinone and piericidin A next to these residues and closer to cluster N2 was modeled into the structure of the bacterial enzyme (10), revealing a marked difference ( fig. S8 ) between the otherwise similar (table S3) . This observation provides a straightforward explanation for the reversible A/D transition (32) occurring only in complex I of some eukaryotes, including Y. lipolytica (33) , and discussed as a protective mechanism against excessive oxygen radical formation (34) . Preparations of Y. lipolytica complex I are always in the so-called deactive (D) form, which slowly reverts into the active (A) form upon addition of substrates (33) . Consistent with the very low catalytic activity of the D form, the structure of Y. lipolytica complex I shows the ubiquinone binding site at markedly greater distance from cluster N2, as compared to the always-active structure of the bacterial enzyme, in which ubiquinone was positioned much closer to its electron donor, allowing for efficient electron transfer (10) . Supporting this interpretation, loop TMH1-2 ND3 undergoes conformational changes during the A/D transition (35) . Considering the remarkably high sequence conservation within the structural elements involved ( fig. S9) (10, 30) and because binding of ubiquinone next to cluster N2 is also supported by exhaustive mutagenesis data for the mitochondrial enzyme (21, 27, 30, 31) , we propose that in the A form, the ubiquinone binding pocket of Y. lipolytica complex I adopts a conformation similar to the bacterial enzyme that has no D form. We suggest that the interface region of complex I can switch between two distinct conformational states, thereby shifting the ubiquinone binding site. This switch involves a concerted movement of loops from three subunits (49-kDa, ND1, and ND3).
Mechanistic implications
The central question concerning the mechanism of energy conversion of complex I is how the redox energy released exclusively in the peripheral arm is transmitted to the proton pump modules of the membrane arm (Fig. 6 ). Several lines of evidence indicate that ubiquinone reduction plays a pivotal role in this process. The hypothetical two-state stabilization-change mechanism (36) proposes that stabilization of negatively charged quinone intermediates drives a conformational change, thereby transmitting energy to the membrane arm to drive proton pumping. It postulates that complex I switches between the E state, in which ubiquinone can be reduced by cluster N2, and the P state, in which it is moved away from its electron donor. This description is reminiscent of the A and D state conformations discussed above. A displacement of the acidic loop TMH5-6 ND1 at the start of the chain of titratable residues reaching through the membrane arm seems ideally suited to transmit an "electrostatic pulse" (37) . We therefore hypothesize that an orchestrated movement of the three loops associated with the A/D transition could also reflect the critical energy-converting steps during catalytic turnover (Fig. 6) . Such a mechanism would imply that the E state corresponds essentially to the A form, whereas the P state would resemble the D form, with the notable exception that the D form cannot revert rapidly and spontaneously to the E/A state, because this is prevented by a yet unidentified structural feature not present in the bacterial enzyme. Because the A/D transition is observed only with eukaryotic enzymes, it is tempting to speculate that stabilization of the D state may involve nearby accessory subunits such as NUEM, which has been shown to take part in the associated conformational changes (38) .
Notably, this series of events could be triggered not only by stabilization of ubisemiquinone, but also of the ubiquinol anion resulting from the second reduction step (36) . Although so far experimental evidence for such a second pump stroke is missing, partitioning of the free energy change by making use of both electron transfer steps to ubiquinone seems to make thermodynamic and mechanistic sense, given that complex I can operate in reverse as a proton gradient-driven NAD + reductase. The described mechanistic principle-chargeinduced conformational changes that result in secondary electrostatic polarization of charged residues-may also be important to drive the individual proton-pumping sites of complex I. Defined localized conformational changes should ensure controlled vectorial charge translocation, whereas energy transfer between the sites could occur by electrostatic coupling. Indeed, recent large-scale molecular dynamics simulations suggested that long-range energy transmission in complex I is executed through charge-induced protonation changes of key residues (39). , which may trigger an electrostatic pulse toward the membrane arm. Stabilization of the anionic species in the site leads to transition from E state (left) to P state (right), driving a stroke of proton pumping. The idling enzyme can convert reversibly from the active A form into the deactive D form with a structure similar to the P state. Fig. 1 ). Single peaks in the bromine anomalous Fourier electron density maps are shown (purple, QA-1, 3.8s; red, QA-2, 4s; superimposition of electron density maps from two separate experiments on structure). Orange, quinazoline ring modeled into the site.
